DefiniGEN Archives – Cambridge Enterprise

Cambridge Enterprise licenses cholangiocyte stem cell technology to DefiniGEN

DefiniGEN raises £1.5M in follow-on funding

There’s life outside the pipeline. Just ask DefiniGEN.

DefiniGEN Licenses Lung Stem Cell Technology from University of Cambridge

microscope image of cells

Horizon Discovery, DefiniGEN collaborate on iPS-based cell lines

DefiniGEN stem cell research plays vital role in developing new drugs

16 February 2015

Another record year for University of Cambridge spin-out investments

10 September 2014

Mouse embryonic stem cells

Definigen raises £1.3m in funding

12 December 2013

SEIS Fund makes its first investments

16 November 2012

The role of stem cells in developing new drugs

30 October 2012